Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study.
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis.
Activation of Invariant NKT Cells in Early Phase of Experimental Autoimmune Encephalomyelitis Results in Differentiation of Ly6Chi Inflammatory Monocyte to M2 Macrophages and Improved Outcome.
The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC.
Human papillomavirus vaccination, induced autoimmunity, and neuromyelitis optica.
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
Absence of mannose-binding lectin in a female with relapsing-remitting multiple sclerosis.
Vitamin D-binding protein and vitamin D status of black Americans and white Americans.
Please mind the gap: axonal transport deficits in multiple sclerosis neurodegeneration.
Prediction of response to interferon therapy in multiple sclerosis.
The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry.
Immune surveillance in multiple sclerosis patients treated with natalizumab.
How Natalizumab Binds and Antagonizes α4 Integrins.
Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis.
Multiple Sclerosis and Venous Abnormalities: Medicine in the Age of Social Media.
Response to "Glucocorticoids for treating Takotsubo syndrome?" and "Atypical global Takotsubo syndrome in a patient with acute disseminated encephalomyelitis".
Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex.
Genetics of primary progressive multiple sclerosis.
Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis.
Electromagnetic Field Stimulation Potentiates Endogenous Myelin Repair by Recruiting Subventricular Neural Stem Cells in an Experimental Model of White Matter Demyelination.
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases.
Riluzole inhibits spontaneous Ca2+ signaling in neuroendocrine cells by activation of K+ channels and inhibition of Na+ channels.
Using a highly abbreviated California Verbal Learning Test-II to detect verbal memory deficits.
Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning.
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Pages
« first
‹ previous
…
155
156
157
158
159
160
161
162
163
…
next ›
last »